These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 31539111)
1. MiR-373 promotes the osteogenic differentiation of BMSCs from the estrogen deficiency induced osteoporosis. Li LY; Wang XL; Wang GS; Zhao HY Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7247-7255. PubMed ID: 31539111 [TBL] [Abstract][Full Text] [Related]
2. MiR-210 promotes bone formation in ovariectomized rats by regulating osteogenic/adipogenic differentiation of bone marrow mesenchymal stem cells through downregulation of EPHA2. Ren L; Zhu X; Tan J; Lv X; Wang J; Hua F J Orthop Surg Res; 2023 Oct; 18(1):811. PubMed ID: 37904187 [TBL] [Abstract][Full Text] [Related]
3. Low-magnitude vibration induces osteogenic differentiation of bone marrow mesenchymal stem cells via miR-378a-3p/Grb2 pathway to promote bone formation in a rat model of age-related bone loss. Yu X; Zeng Y; Bao M; Wen J; Zhu G; Cao C; He X; Li L FASEB J; 2020 Sep; 34(9):11754-11771. PubMed ID: 32652777 [TBL] [Abstract][Full Text] [Related]
4. Down-regulated microRNA-199a-3p enhances osteogenic differentiation of bone marrow mesenchymal stem cells by targeting Kdm3a in ovariectomized rats. Wu JC; Sun J; Xu JC; Zhou ZY; Zhang YF Biochem J; 2021 Feb; 478(4):721-734. PubMed ID: 33410908 [TBL] [Abstract][Full Text] [Related]
5. MiR-203 is essential for the shift from osteogenic differentiation to adipogenic differentiation of mesenchymal stem cells in postmenopausal osteoporosis. Qiao L; Liu D; Li CG; Wang YJ Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5804-5814. PubMed ID: 30280759 [TBL] [Abstract][Full Text] [Related]
6. LncRNA MEG3 inhibited osteogenic differentiation of bone marrow mesenchymal stem cells from postmenopausal osteoporosis by targeting miR-133a-3p. Wang Q; Li Y; Zhang Y; Ma L; Lin L; Meng J; Jiang L; Wang L; Zhou P; Zhang Y Biomed Pharmacother; 2017 May; 89():1178-1186. PubMed ID: 28320084 [TBL] [Abstract][Full Text] [Related]
7. lncTIMP3 promotes osteogenic differentiation of bone marrow mesenchymal stem cells via miR-214/Smad4 axis to relieve postmenopausal osteoporosis. Wumiti T; Wang L; Xu B; Ma Y; Zhu Y; Zuo X; Qian W; Chu X; Sun H Mol Biol Rep; 2024 Jun; 51(1):719. PubMed ID: 38824271 [TBL] [Abstract][Full Text] [Related]
8. MiR-27a is Essential for the Shift from Osteogenic Differentiation to Adipogenic Differentiation of Mesenchymal Stem Cells in Postmenopausal Osteoporosis. You L; Pan L; Chen L; Gu W; Chen J Cell Physiol Biochem; 2016; 39(1):253-65. PubMed ID: 27337099 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-182 inhibits osteogenic differentiation of bone marrow mesenchymal stem cells by targeting Smad1. Zheng HB; Wu M; Zhang G; Chen KL J Biol Regul Homeost Agents; 2021; 35(2):505-516. PubMed ID: 33691396 [TBL] [Abstract][Full Text] [Related]
10. Applying vibration in early postmenopausal osteoporosis promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells and suppresses postmenopausal osteoporosis progression. Li H; Wu W; He X; Cao C; Yu X; Zeng Y; Li L Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31406012 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol alleviates osteoporosis through improving the osteogenic differentiation of bone marrow mesenchymal stem cells. Chen XH; Shi ZG; Lin HB; Wu F; Zheng F; Wu CF; Huang MW Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6352-6359. PubMed ID: 31364143 [TBL] [Abstract][Full Text] [Related]
12. MiR-133 is Involved in Estrogen Deficiency-Induced Osteoporosis through Modulating Osteogenic Differentiation of Mesenchymal Stem Cells. Lv H; Sun Y; Zhang Y Med Sci Monit; 2015 May; 21():1527-34. PubMed ID: 26013661 [TBL] [Abstract][Full Text] [Related]
13. microRNA-935-modified bone marrow mesenchymal stem cells-derived exosomes enhance osteoblast proliferation and differentiation in osteoporotic rats. Zhang Y; Cao X; Li P; Fan Y; Zhang L; Ma X; Sun R; Liu Y; Li W Life Sci; 2021 May; 272():119204. PubMed ID: 33581127 [TBL] [Abstract][Full Text] [Related]
14. Protective effect of resveratrol on estrogen deficiency-induced osteoporosis though attenuating NADPH oxidase 4/nuclear factor kappa B pathway by increasing miR-92b-3p expression. Zhang Y; Liu MW; He Y; Deng N; Chen Y; Huang J; Xie W Int J Immunopathol Pharmacol; 2020; 34():2058738420941762. PubMed ID: 32674689 [TBL] [Abstract][Full Text] [Related]
15. [Melatonin promotes osteogenesis of bone marrow mesenchymal stem cells by improving the inflammatory state in ovariectomized rats]. Guan H; Cao R; Zhao Y; Zhang J; Li H; Duan X; Li Y; Kong N; Tian R; Wang K; Yang P Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2023 Aug; 37(8):1011-1020. PubMed ID: 37586803 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of miRNA-100 facilitates bone regeneration defects of mesenchymal stem cells in osteoporotic mice through the protein kinase B pathway. Dai Z; Wei G Bioengineered; 2022 Jan; 13(1):963-973. PubMed ID: 35132915 [TBL] [Abstract][Full Text] [Related]
17. Estrogen deficiency does not decrease the in vitro osteogenic potential of rat adipose-derived mesenchymal stem cells. Veronesi F; Pagani S; Della Bella E; Giavaresi G; Fini M Age (Dordr); 2014 Jun; 36(3):9647. PubMed ID: 24687841 [TBL] [Abstract][Full Text] [Related]
18. LncRNA LOXL1-AS1 controls osteogenic and adipocytic differentiation of bone marrow mesenchymal stem cells in postmenopausal osteoporosis through regulating the miR-196a-5p/Hmga2 axis. Zhang L; Xie H; Li S J Bone Miner Metab; 2020 Nov; 38(6):794-805. PubMed ID: 32651705 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of miR-339 promotes differentiation of BMSCs and alleviates osteoporosis by targeting DLX5. Zhou J; Nie H; Liu P; Wang Z; Yao B; Yang L Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):29-36. PubMed ID: 30657543 [TBL] [Abstract][Full Text] [Related]
20. Effect of GGCX on the differentiation function of osteoporosis bone marrow mesenchymal stem cells through regulating TGFβ/smad signaling pathway. Wang QL; Li HF; Wang DP; Liu ZY; Xiao WW; Xu LL; Yu S Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7224-7231. PubMed ID: 31539109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]